IDEAYA Biosciences, Inc. (IDYA) Profit Margin
IDEAYA Biosciences, Inc. (IDYA) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | -176.55% |
| 2021-12-31 | -178.10% |
| 2022-12-31 | -115.17% |
| 2023-12-31 | -483.05% |
| 2024-12-31 | -3921.10% |
| 2025-12-31 | -51.99% |
How IDYA compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc. | 30.16% |
| SPRO | Spero Therapeutics Inc. | 12.83% |
| ACHV | Achieve Life Sciences Inc. | -24.38% |
| ARVN | Arvinas Inc. | -30.77% |
| RGNX | REGENXBIO Inc. | -113.75% |
These are five companies in the same sector as IDYA with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get IDEAYA Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("IDYA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IDYA | $36.74 | -0.76% | 0.72M |
| 3 | ||||
| 4 | ||||
| 5 |